 | Up a level |
2022
Salmanton-Garcia, Jon, Stewart, Fiona A., Heringer, Sarah, Koniordou, Markela 
ORCID: 0000-0002-6034-1291, Alvarez-Barco, Elena, Argyropoulos, Christos D. ORCID: 0000-0002-2090-2162, Themistocleous, Sophia C., Valle-Simon, Paula, Spivak, Orly, Souckova, Lenka, Merakou, Christina, Mendonca, Maria Amelia, Davis, Ruth Joanna, Azzini, Anna Maria, Askling, Helena H., Vene, Sirkka, Van Damme, Pierre, Steinbach, Angela, Shiamakkides, George, Seidel, Danila, Olesen, Ole F., Noula, Evgenia, Macken, Alan, Luis, Catarina, Leckler, Janina, Launay, Odile, Isitt, Catherine, Hellemans, Margot ORCID: 0009-0005-2926-1559, Frias-Iniesta, Jesus, Di Marzo, Romina, Carcas, Antonio J., Boustras, George, Borobia, Alberto M., Barta, Imre, Albus, Kerstin, Akova, Murat, Ochando, Jordi, Cohen-Kandli, Miriam, Cox, Rebecca Jane, Husa, Petr ORCID: 0000-0002-9190-2610, Jancoriene, Ligita, Mallon, Patrick ORCID: 0000-0002-4337-6222, Marques, Laura, Mellinghoff, Sibylle C., Naucler, Pontus, Tacconelli, Evelina, Toth, Krisztina, Zaoutis, Theoklis E., Zeitlinger, Markus ORCID: 0000-0002-1873-3953, Cornely, Oliver A. ORCID: 0000-0001-9599-3137 and Pana, Zoi-Dorothea
(2022).
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment.
Vaccine, 40 (31).
S. 4090 - 4098.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1873-2518
2016
Pett, Sarah Lilian, Amin, Janaki ORCID: 0000-0003-2161-9366, Horban, Andrejz, Andrade-Villanueva, Jaime, Losso, Marcelo, Porteiro, Norma, Sierra Madero, Juan, Belloso, Waldo, Tu, Elise, Silk, David, Kelleher, Anthony ORCID: 0000-0002-0009-3337, Harrigan, Richard, Clark, Andrew, Sugiura, Wataru, Wolff, Marcelo ORCID: 0000-0002-9956-8872, Gill, John, Gatell, Jose, Fisher, Martin, Clarke, Amanda, Ruxrungtham, Kiat, Prazuck, Thierry, Kaiser, Rolf, Woolley, Ian, Alberto Arnaiz, Juan, Cooper, David, Rockstroh, Jurgen K., Mallon, Patrick and Emery, Sean ORCID: 0000-0001-6072-8309
(2016).
Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study.
Clin. Infect. Dis., 63 (1).
S. 122 - 133.
CARY:
OXFORD UNIV PRESS INC.
ISSN 1537-6591